February 2021 FDA Recall Pantoprazole Sodium by Sun Pharmaceutical Industries Inc
D-0251-2021 - Failed Impurity/Degradation Specifications

This Class III drug recall was voluntarily initiated by Sun Pharmaceutical Industries Inc on February 5, 2021 for the product Pantoprazole Sodium. The FDA reported the reason for recall as failed impurity/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0251-2021

Reason for Recall
Failed Impurity/Degradation Specifications
Initiated
02-05-2021
Reported
02-17-2021
Quantity
20,475 vials

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
SUN PHARMACEUTICAL INDUSTRIES INC
Pantoprazole Sodium for Injection 40mg/vial For I.V. infusion only Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 62756-129-40

Batch or Lot Expiration Information

Lot# JKU3595A, JKU3596A, JKU3597A, and JKU3629A; Exp 02/2021